跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
A-011
首页
药物
A-011
A-011
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse
US 2009041659 A1
申请人: SCHREIBER JOHN R
优先权: 2004
US
3 件公开
Methods for treating Alzheimer's disease by administering certain synthetic compounds
US 9084793 B2
申请人: BEIJING JOEKAI BIOTECHNOLOGY LLC
优先权: 2013
US
2 件公开
Adrenic acid receptor and uses thereof
US 2003073815 A1
申请人: ROBAS NICOLA M
优先权: 2002
US
Glucan ferroferric oxide magnetic nano-material and the preparing method thereof and the application
CN 101062416 A
申请人: WUHAN UNION HOSPITAL
优先权: 2006
CN
Anti-LPS 011 antibody
CN 105849262 A
申请人: DAIICHI SANKYO CO LTD
优先权: 2013
CN
Solution formulations of CX-011
US 11974993 B2
申请人: HOPE CITY
优先权: 2022
US
Application of cGAS-STING signal channel inhibitor in preparation of medicine for preventing or treating sepsis
CN 118403042 A
申请人: THE FIRST MEDICAL CENTER OF CHINESE PLA GENERAL HOSPITAL
优先权: 2024
CN
Pharmaceutical composition of SN-011 and application thereof
CN 121622922 A
申请人: UNIV CHINA PHARMA
优先权: 2024
CN
Application of compound EG-011 and pharmaceutical composition thereof in resisting influenza A virus
CN 120284973 A
申请人: UNIV HUAZHONG AGRICULTURAL
优先权: 2025
CN
肝脏20-HETE合成抑制剂在制备治疗围绝经期情绪障碍药物中的应用
CN 121129861 B
申请人: 北京大学
优先权: 2025
CN
第 1 / 2 页
上一页
下一页
药物
反馈